Mebendazole and cancer: what does the evidence actually show?
Why a cheap deworming drug excites some patients, and why an oncologist urges caution.
What this episode covers
- Mebendazole is an old, safe antiparasite drug now studied as a possible cancer treatment.
- In the lab it can kill cancer cells and slow tumor blood supply.
- But most lab successes fail in people, and here the human evidence is small and unclear.
- An oncologist frames it as worth studying, not yet a proven treatment.
Confidence in this episode
Everything about how much to believe this episode, in one place.
Lab evidence is real but preclinical. Human data is a few small studies and anecdotes, often without controls, so benefit in people is not established.
- Mebendazole kills several cancer cell types and slows tumor blood supply in the lab.
- The drug has a long safety record as an antiparasite treatment.
- Whether it reaches useful levels in the body at safe doses.
- Whether it helps people, given only small and anecdotal human data.
- How it interacts with standard cancer treatments.
Why it matters
Repurposing a cheap, safe drug against cancer is an appealing idea. Mebendazole shows real promise in the lab, which is why patients ask about it. It matters because lab promise often does not survive human trials, and the drug absorbs poorly. Understanding that gap helps people weigh hope against evidence without giving up standard care.
What stands out
- About 95% of drugs that work in the lab fail in human trials, often over safety, dosing, or lack of effect.
- A drug being cheap and safe does not mean it works against cancer.
- Anecdotes of success often can't separate the drug from standard treatment taken alongside it.
Best-supported action
The single highest-leverage move from this episode, anchored in the strongest evidence the speaker presents.
If you are considering mebendazole, talk with your oncologist first, since it is not proven and can interact with treatment.
Where to start
Small low-friction starters covering the main moves from this episode.
- Bring any interest in mebendazole to your oncology team rather than self-treating.
- Ask whether a clinical trial is available if you want to pursue it.
- Treat dramatic online cure stories with caution, since anecdotes lack controls.
Other supported actions
Further actions discussed in this episode, ordered from strongest to weakest evidence. This is one expert's view, the full topic compares and ranks across experts.
- Consider raising mebendazole with your oncologist before trying anything.Limited evidence
- Consider asking about clinical trials rather than self-treating.Limited evidence
- Consider judging online success stories cautiously, since they lack controls.Limited evidence
Full context, impact ratings, and timing — available in related topics
Questions to take to your doctor
- Given my diagnosis, is there any trial evidence for mebendazole that applies to me?
- Given I'm curious, could it interfere with my current treatment or cause harm?
- Given the limited data, is a clinical trial a better route than trying it on my own?
Full doctor prep with ranked questions available in the full topic page
Context
This does not prove mebendazole treats cancer in people. The strong evidence is preclinical, not clinical.
Human reports are few, small, and often uncontrolled, so they cannot show benefit reliably.
The drug absorbs poorly, so reaching helpful levels safely is uncertain, and rare serious effects exist.
This is general information, not medical advice. This does not mean you should change or stop cancer treatment on your own. Discuss any option with your oncologist.
Where people go wrong
- Replacing or delaying standard cancer treatment to try mebendazole.Can lose the window for treatments that are actually proven to help.
- Reading anecdotes as proof the drug worked.Anecdotes can't separate the drug from other care, so they mislead.
What to expect over time
- AskInterest is raised with the oncology team, not acted on alone.
- CheckTrial options and interactions with current treatment are reviewed.
- DecideAny step is taken with medical guidance, keeping standard care.